Compass Therapeutics

parachute chutes
Biotech

Roche, Vir, Neurocrine & more—Chutes & Ladders

Roche bids adieu to pharma vet Sabry. Vir fills vacant CMO spot. Neurocrine maps out CEO succession plan.
Handshake

Compass inks Trigr takeover to land clinical-phase bispecific

May 14, 2021 8:35am
Compass in a mans hand

Compass aims at $50M IPO to push lead antibody through clinic

Oct 20, 2020 9:50am
Mouse

Compass' immuno-oncology prospect clears solid tumors in mice

Apr 3, 2020 8:50am
Seattle

Biomatics raises $300M fund, recruits biopharma vets

Nov 8, 2018 10:10am
Boston skyline from harbor

2018’s Fierce 15 on biotech investment and the next decade

Oct 3, 2018 11:06am